Chemoinformaics analysis of [(1R,2R,5R)-6,6-DIMETHYL-2-BICYCLO[3.1.1]HEPTANYL]METHANOL
| Molecular Weight | 154.253 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 17 |
| Exact Molecular Weight | 154.136 | nRing | 3 |
| Solubility: LogS | -2.975 | nHRing | 0 |
| Solubility: LogP | 1.675 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.504 |
| Synth | 5.309 |
| Natural Product Likeliness | 3.624 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.902 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.533 |
| MDCK | 0.0000313 |
| BBB | 0.101 |
| PPB | 0.833962 |
| VDSS | 0.529 |
| FU | 0.145389 |
| CYP1A2-inh | 0.026 |
| CYP1A2-sub | 0.161 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.4 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.054 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.118 |
| CYP3a4-inh | 0.191 |
| CYP3a4-sub | 0.203 |
| CL | 4.235 |
| T12 | 0.817 |
| hERG | 0.028 |
| Ames | 0.047 |
| ROA | 0.046 |
| SkinSen | 0.126 |
| Carcinogencity | 0.64 |
| EI | 0.085 |
| Respiratory | 0.845 |
| NR-Aromatase | 0.795 |
| Antiviral | No |
| Prediction | 0.942817 |